Financials Hongchang International Co., Ltd

Equities

HCIL

US42831T2024

Pharmaceuticals

Market Closed - OTC Markets 02:34:20 2024-06-06 pm EDT 5-day change 1st Jan Change
0.2001 USD 0.00% Intraday chart for Hongchang International Co., Ltd 0.00% -42.63%

Valuation

Fiscal Period: December 2023
Capitalization 1 181
Enterprise Value (EV) 2 180.1
P/E ratio -415 x
Yield -
Capitalization / Revenue 67,631,783 x
EV / Revenue 67,297,029 x
EV / EBITDA -472 x
EV / FCF -2,648,387 x
FCF Yield -0%
Price to Book 4.47 x
Nbr of stocks (in thousands) 518,831
Reference price 3 0.3488
Announcement Date 4/1/24
1USD in Million2CNY in Million3USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2021 2022 2023
Net sales - - 2.676
EBITDA 1 -0.265 -0.994 -0.3815
EBIT 1 -0.886 -1.615 -0.4696
Operating Margin - - -17.55%
Earnings before Tax (EBT) 1 -0.877 -1.615 -0.4447
Net income 1 -0.877 -1.615 -0.3788
Net margin - - -14.16%
EPS 2 -0.1754 -0.3230 -0.000841
Free Cash Flow - 162.8 -67.99
FCF margin - - -2,541.06%
FCF Conversion (EBITDA) - - -
FCF Conversion (Net income) - - -
Dividend per Share - - -
Announcement Date 9/7/23 9/7/23 4/1/24
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2021 2022 2023
Net Debt 1 31.8 43.8 -
Net Cash position 1 - - 0.9
Leverage (Debt/EBITDA) -119.9 x -44.03 x -
Free Cash Flow - 163 -68
ROE (net income / shareholders' equity) - 93% -1.89%
ROA (Net income/ Total Assets) - -0.82% -0.72%
Assets 1 - 197.1 52.57
Book Value Per Share 2 -0.1900 -0.5100 0.0800
Cash Flow per Share 2 0 0 0
Capex 1 0.49 10.5 40.6
Capex / Sales - - 1,517.17%
Announcement Date 9/7/23 9/7/23 4/1/24
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. HCIL Stock
  4. Financials Hongchang International Co., Ltd